Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Coral Laboratories Ltd (524506)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524506 NSE: Pharmaceuticals & Drugs | Small Cap | Coral Laboratories Share Price
₹579 -1.75 (-0.30%)
As on 23-Sep'26 11:42
Coral Laboratories Ltd (524506)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524506 NSE: Pharmaceuticals & Drugs | Small Cap | Coral Laboratories Share Price
₹579 -1.75 (-0.30%)
As on 23-Sep'26 11:42
Key Metrics
Valuation Multiples
Market Cap
₹207 Cr.
Current Price
₹579
52-Week Low / High
₹360 / 679
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
54.8
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
37.47%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
71.51%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹3.6 Cr.
Face Value
₹10
All Time Low / High
₹7.25 / 1190.00
Check Before You Invest
Quality
Not GoodValuation
Somewhat OvervaluedCheck Valuation charts
Price Trend
Weak
Is Coral Laboratories Ltd a good quality company?
Coral Laboratories Ltd is a weak quality company, based on a inconsistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Coral Laboratories Ltd performance compare with that of its Peers?
Revenue growth of Coral Laboratories Ltd vs industry peers?
Coral Laboratories Ltd revenue CAGR is %, compared to the industry median CAGR of 0%, indicating stable growth and maintaining its market share.
Promoter shareholding and pledge status of Coral Laboratories Ltd?
Promoters hold 71.51% of the Coral Laboratories Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Coral Laboratories Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 2.2% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Coral Laboratories Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 26.9% | 27.2% | 15.9% | 13.4% | 7.9% | 13.4% | 7.9% | 5.4% | 12.5% | 17% | - |
| Value Creation Index ⓘ | 0.9 | 1.0 | 0.1 | 0.0 | -0.4 | -0.1 | -0.4 | -0.6 | -0.1 | 0.2 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 77 | 95.5 | 92.5 | 91.1 | 70.6 | 96.6 | 75.6 | 78.1 | 83.7 | 115 | 97 |
| Sales YoY Gr. | - | 24% | -3.1% | -1.5% | -22.5% | 36.8% | -21.7% | 3.3% | 7.1% | 37.5% | - |
| Adj EPS ⓘ | 32.9 | 46.2 | 32.6 | 25.4 | 16.6 | 37.9 | 22.6 | 11.6 | 42.7 | 66.2 | 53.8 |
| YoY Gr. | - | 40.5% | -29.3% | -22.1% | -34.8% | 128.6% | -40.4% | -48.6% | 266.7% | 55.2% | - |
| BVPS (₹) ⓘ | 196.4 | 305.5 | 325.6 | 318.5 | 323.8 | 382.5 | 436.8 | 433.3 | 496.8 | 563.2 | 600.4 |
| Adj Net Profit ⓘ | 11.7 | 16.5 | 11.7 | 9.1 | 5.9 | 13.6 | 8.1 | 4.2 | 15.2 | 23.7 | 19 |
| Cash Flow from Ops. ⓘ | 5.1 | 10.8 | 13.5 | -0.9 | -3.9 | 0.9 | 6.1 | 12.7 | -5.5 | -1.2 | - |
| Debt/CF from Ops. ⓘ | 0.1 | 0.2 | 0.1 | -1.6 | -1.5 | 6.7 | 1 | 0 | 0 | -2.9 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 4.6% | 10.3% | 15% | 37.5% | ||||
| Adj EPS ⓘ | 8.1% | 31.9% | 43.1% | 55.2% | ||||
| BVPSⓘ | 12.4% | 11.7% | 8.8% | 13.4% | ||||
| Share Price | 1.9% | 7.2% | 28.2% | 14.6% | ||||
Key Financial Parameters ⓘ
| Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 18.2 | 18.4 | 10.3 | 7.9 | 5.2 | 10.7 | 5.5 | 2.7 | 9.2 | 12.5 | 9.2 |
| Op. Profit Mgn % ⓘ | 21.4 | 24.4 | 16.6 | 13.6 | 7.7 | 16.4 | 10.9 | 4.9 | 19.4 | 22.8 | 19.2 |
| Net Profit Mgn % ⓘ | 15.2 | 17.3 | 12.6 | 10 | 8.4 | 14 | 10.7 | 5.3 | 18.2 | 20.6 | 19.9 |
| Debt to Equity ⓘ | 0 | 0 | 0 | 0 | 0.1 | 0.1 | 0 | 0 | 0 | 0 | - |
| Working Cap Days ⓘ | 241 | 229 | 243 | 247 | 332 | 273 | 382 | 346 | 301 | 226 | 345 |
| Cash Conv. Cycle ⓘ | 127 | 127 | 140 | 129 | 181 | 146 | 213 | 180 | 120 | 92 | 302 |
Valuation of Coral Laboratories - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Coral Laboratories Ltd FAQs
The current trading price of Coral Laboratories on 23-Sep-2026 11:42 is ₹579.0.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 22-Sep-2026 the market cap of Coral Laboratories stood at ₹207.5 Cr
The latest P/E ratio of Coral Laboratories as of 22-Sep-2026 is 10.80.
The latest P/B ratio of Coral Laboratories as of 22-Sep-2026 is 0.97.
The 52-week high of Coral Laboratories is ₹679.0 and the 52-week low is ₹360.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Coral Laboratories is ₹96.70 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Coral Laboratories Ltd is a below average quality company.
The key valuation ratios of Coral Laboratories Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Coral Laboratories Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Coral Laboratories Ltd
Coral Laboratories was founded in 1994. The company is equipped with an ultra modern manufacturing unit in the state of Gujarat, Daman & today is a force to reckon with in the pharmaceutical industry; a fact which has been endorsed by the WHO GMP certification issued by the Food & Drugs Control Administration and ISO 9001-2000 Quality certification issued by American Quality Assessors.
The Company with deep basket of products is focused in hostlic human welfare and is bringing planfort to people with its Inflammatory, Bacterial, Biotic, Protein deficiencies & Skin conditions. Medicines across the nation, manufactured under the ZEST group & MOXBRO group being the most popular brands across the nation, manufactured by the company.Coral Laboratories has been following a steady growth path on the pillars of its philosophy of “Total Quality Management†& “Quality Products at Affordable Pricesâ€.
The state-of-the art manufacturing facilities meet the stringent and over changing quality requirement of the most discerning buyers. Coral has a multi location manufacturing facilities based on Baroda, Daman & Vasai for strategies convenience. The facilities carrying WHO-GMP & ISO 9001 : 2000 certification. The new manufacturing facilities under expansion to have UK – MHRA and US– FDA certification.
Coral has one of the best quality control laboratory in indian pharmaceuticals industry equipped with latest and sensitive laboratory instruments.
Product range of the company includes:
- Capsules & Dry Syrups
- Tablets
- Liquid Orals
- Kits
- Ointment & Cream
- Injection – Eye – Ear Drops
- Others
Achievements/ recognition:
- WHO GMP certification issued by the Food & Drugs Control Administration
- ISO 9001-2000 Quality certification issued by American Quality Assessors.
You have 44 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
